WSJ : Hewlett Packard Enterprise Near Deal to Buy Juniper Networks

Hewlett Packard Enterprise Near Deal to Buy Juniper Networks
Deal could be unveiled this week, valuing Juniper at roughly $13 billion

Hewlett Packard Enterprise HPE 3.20%increase; green up pointing triangle is in advanced talks to buy Juniper Networks JNPR 1.04%increase; green up pointing triangle for about $13 billion, in a bid to better position the nearly 100-year-old technology company in the era of artificial intelligence.

A deal between the two companies could be announced as soon as this week, according to people familiar with the matter, assuming the talks don’t fall apart.

Texas-based HPE, as Hewlett Packard Enterprise is known, is a cloud-services provider to customers ranging from small businesses to large corporations and governments. HPE is an offshoot of the iconic tech company founded in 1939 by William Hewlett and David Packard, Hewlett-Packard.

HPE shares closed Monday at $17.72, bringing its market capitalization to roughly $23 billion.

Juniper’s stock ended trading at $30.22, taking its market value to about $9.6 billion. A tech-bubble-era darling, its shares have languished for years and currently trade at a fraction of what they once fetched.

Sunnyvale, Calif.-based Juniper sells communications-network services and equipment like routers and switches to technology, telecommunications, financial and other customers.

Juniper also operates a growing artificial intelligence business, known as Mist AI, which it says uses AI and machine learning to optimize users’ experiences around wireless access.

In 2015, HPE was split between an enterprise-services producer and a computer and printer maker known as HP.

A deal between HPE and Juniper would be one of the biggest recent technology takeovers. Tech, normally the biggest engine of merger volume, has been in the doldrums amid a slowdown in dealmaking, hit particularly hard by tougher antitrust scrutiny out of Washington.

But in another big deal in the industry that is in the works, The Wall Street Journal reported last week that design-software company Synopsys is in advanced talks to acquire Ansys for around $35 billion in stock and cash.

WSJ : Tinder Owner Match Draws Elliott Investment

Tinder Owner Match Draws Elliott Investment
Activist has roughly $1 billion stake and intends to meet with Match to discuss ways to improve online dating company’s performance

Elliott Investment Management has built a big stake in Match Group MTCH 3.30%increase; green up pointing triangle and plans to push the online dating company to take steps to boost its languishing stock.

The activist has built a position of roughly $1 billion in Match, the parent company of Tinder, Hinge and other dating platforms, according to people familiar with the matter.

Elliott intends to discuss with Match ways to turn the company’s performance around. The hedge fund’s specific demands, and whether or not it plans to pursue nominating director candidates, couldn’t be learned.

Match shares closed Monday at $37.89, bringing the company’s market capitalization to roughly $10 billion. In 2021, amid the Covid-19 pandemic and a boom in internet stocks, Match’s market capitalization soared well above $40 billion. More recently, a decline in paying customers and other factors have hurt the stock.

Besides Tinder and Hinge, Dallas-based Match’s portfolio of dating platforms includes OkCupid and Plenty of Fish, in addition to its namesake Match brand. New York media and internet holding company IAC/InterActive previously owned Match but fully separated from it in 2020.

The business dwarfs its publicly traded rivals including Bumble, valued at nearly $2 billion, and Grindr, about $1.5 billion.

Match’s Tinder app, the biggest dating site in the world by user count, booked roughly $1.8 billion in revenue in 2022, up 9% from 2021. Revenue for Hinge, its fastest-growing platform, surged 44% year over year.

More recently, analysts and investors have raised concerns about Tinder’s growth slowing earlier and more severely than expected. Match has also seen continued turnover in its C-suite, provoking some shareholder unease.

Match most recently named Bernard Kim, previously chief executive of Zynga, as CEO in 2022. Kim also oversees the Tinder business, according to the company’s website.

In November, Match reported third-quarter results that showed a continued decline in the number of “payers” on the Tinder app. The company further forecast that the drop was expected to get even worse in the current quarter, as Match felt the impact of price increases it began enacting earlier in 2023.

The company has said, however, the slowdown is a shorter-term blip in its broader turnaround plans. Its Hinge business, meanwhile, is expected to hit $1 billion in revenue in the next four years, analysts predict.

Elliott is known for taking on tech companies and others and forcing changes that include sales. One of the biggest and busiest activists, it has recently pursued campaigns at companies including Salesforce and Pinterest.

Elliott also recently gained a victory at wireless-tower owner Crown Castle, which in late December announced a review of its fiber business and replaced two directors on its board as part of a pact with the hedge fund that had been pushing for changes.

FT : Russian oligarch faces off against Sotheby’s in trial over art sales

Russian oligarch faces off against Sotheby’s in trial over art sales
Dmitry Rybolovlev is seeking millions in damages over the purchase of famous works

A trial pitting Russian billionaire Dmitry Rybolovlev against Sotheby’s auction house began on Monday in New York, the latest stage in a sweeping legal saga that has roiled the art world.

Rybolovlev has sued Sotheby’s in Manhattan federal court and accused it of helping a high-profile art dealer vastly inflate the prices of famed pieces of art, including Leonardo da Vinci’s “Salvator Mundi”, before he purchased them.

Rybolovlev is seeking $377mn in damages from Sotheby’s as part of a long-running dispute over works he bought through Yves Bouvier, his agent for more than 10 years.

The oligarch claimed Bouvier posed as an agent helping to broker sales of the rare art, when in fact he was working as a dealer, buying the art from the auction house himself and quickly reselling it to Rybolovlev at a mark-up. Rybolovlev became a collector of valuable artwork after selling his holdings in Russian potash fertiliser producer Uralkali for $6.5bn in 2010. He also subsequently purchased AS Monaco, the football club.

He has alleged that Bouvier sold him René Magritte’s “Le Domaine d’Arnheim” and Amedeo Modigliani’s “Tête”, for substantially more than he had paid for them at Sotheby’s, and that the auction house provided documents to help ensure that Rybolovlev trusted the final price and obscure that Bouvier was the true owner of the art. He has described the 12-year scheme as “the largest art fraud in history”.

The case revolves around just four sales, a portion of the estimated $2bn of art Rybolovlev purchased from Bouvier over that time.

It provides a rare glimpse into the world of private art sales, where anonymity and discretion are typically paramount, and how transactions worth hundreds of millions of dollars are brokered between prestigious auction houses and the world’s richest collectors in secret.

Sotheby’s lawyers argued that Rybolovlev could not prove the auction house had involvement in any alleged wrongdoing.

“Sotheby’s business is to bring together a seller and a buyer and make a sale happen,” said Sara Shudofsky, a lawyer for Sotheby’s, in her opening remarks on Monday, in front of a 10-member jury that included a nurse, a nursery school teacher and a church organist. Selling art to Bouvier was in the company’s interests, it has argued, claiming it had no idea he planned to quickly flip the works for millions of dollars more than what he paid.

The auction house argued that Rybolovlev, who has amassed a fortune of about $7bn, did not take any measures to verify the provenance or the last price of the artworks he was purchasing, and said Rybolovlev had an “unreasonable” reliance on Bouvier. Rybolovlev “has every right to be mad at himself . . . for not taking the most simple, basic steps to protect [his] interests,” said Shudofsky.

Daniel Kornstein, a lawyer for Rybolovlev, called Sotheby’s involvement in the sales of the contested works a “trail of treachery”, and accused a representative for the auction house who worked closely with Bouvier on his purchases of helping to “plunder” Rybolovlev, by using Sotheby’s reputation to add credibility to Bouvier’s subsequent sales to the oligarch.

Kornstein drew upon another masterwork — “A Sunday Afternoon on the Island of La Grande Jatte” by pointillist Georges Seurat — when laying out the case to jurors. Looking at each individual piece of evidence, he said, “up close it is just dots”. But step back far enough, “and a picture will emerge”.

Bouvier, who was not a defendant in the Sotheby’s case, settled a separate criminal dispute in Switzerland last month, the last outstanding criminal case against the art dealer over the Rybolovlev affair. Another civil case against Bouvier in Singapore was also terminated as part of the settlement, the details of which remain confidential. He has denied any wrongdoing.

The federal civil trial in New York, which is expected to last a month, features a witness list that is a who’s who of the high art world including powerful dealers Larry Gagosian and Sandy Heller.

FT : European space agency warns ‘no guarantee’ for Ariane in rocket launch mark

European space agency warns ‘no guarantee’ for Ariane in rocket launch market
Airbus and Safran under pressure as ESA promotes competition to spur Europe’s new space economy

There is “no guarantee” France’s ArianeGroup will continue to be Europe’s rocket launch company of choice according to the head of the European Space Agency, after ESA member states agreed to introduce more competition to the market.

Josef Aschbacher, the agency’s director-general, told the Financial Times in an interview that the decision in November to open the European launcher market to competition was a “game-changer”.

The next generation of launch would be done “in a very different way,” he said, acknowledging that this would put pressure on ArianeGroup’s owners, Airbus and Safran. “If they have a very competitive launcher then they are in the race. But there is no guarantee.” 

Martin Sion, chief executive of ArianeGroup, which since 2017 has lost its dominance of the commercial launch market to Elon Musk’s SpaceX, said the company was ready for the challenge. “The rules are changing, we will adapt,” he said. “We are used to competition.”  

However, Aschbacher’s comments are a clear warning to ArianeGroup, which has suffered serial delays on its latest launcher, Ariane 6, now expected to be four years late.

As a result of the delays, and problems with the smaller Vega-C, which is manufactured by Italy’s Avio, Europe has had to use SpaceX to send some of its most important satellites into orbit. 

In November, France, Germany and Italy agreed to inject new funds into the Ariane 6 programme, but the rocket is not reusable and will still be more expensive than SpaceX’s workhorse Falcon 9 when it finally launches around the middle of the year.

Guillaume Faury, Airbus chief executive, said in a separate interview that competition posed a serious challenge to ArianeGroup. “As one of the two shareholders, we are worried, as Ariane is today the incumbent,” he said. “The way to take our share is to make sure Ariane 6 will be a success.”

He acknowledged that Europe needed to find a more “market-driven” way to compete with lower-cost providers such as SpaceX but suggested it should not give up on Ariane in favour of a range of competing programmes. Fragmentation would be “a disaster”, he said.

If the “result [of competition] is a different way being united around a small number of programmes, where states put their efforts together to compete against the real competitors, which are . . . mainly SpaceX and the Chinese to come, that is OK,” he told the FT. “But the jury is out. For the moment what we observe is further fragmentation.”

Yet the ESA is determined to shake up the European commercial space sector by emulating the approach of Nasa. Over the past two decades, the US space agency has shifted from buying rockets from incumbents such as Boeing and Lockheed’s United Launch Alliance, to booking flight services. 

By giving contracts to disruptive newcomers such as SpaceX, Nasa has ensured the success of Elon Musk’s rocket company and the cost of launching into space has fallen significantly.

“Competition is certainly the solution. It is a way of reducing cost and this is what we are planning to do in the next generation,” Aschbacher said. ESA has also challenged the private sector to develop a cargo vehicle that might eventually carry crew to the International Space Station by 2028, reducing its reliance on US providers.

Germany in particular is keen on more competition in the launcher market, as the home of some of Europe’s most advanced rocket start-ups such as Isar Aerospace and Rocket Factory Augsburg.

Although ArianeGroup was currently Europe’s only producer of heavy lift rockets, it was possible that new rivals could upset its monopoly for the generation after Ariane 6, said Caleb Henry, director of research at consultancy Quilty Space.

SpaceX “had a smaller rocket and reached space. That was enough to get . . . a significant chunk of the Department of Defense market,” he said. “So it is not at all a stretch to say someone developing a smaller rocket today could be making an Ariane-sized rocket tomorrow.”

FT : Crop chemicals boost drug resistance of killer fungi, scientists warn

Crop chemicals boost drug resistance of killer fungi, scientists warn
Medical experts call for curbs on agricultural fungicides

Fungicides applied to agricultural crops are contributing to a rising death toll from fungal infections by driving the evolution of drug-resistant strains, scientists warn.

As they work to develop compounds that target fungal infections in humans, scientists are urging the agrochemical industry and its regulators to pay more attention to the health implications of cross-resistance, which enables fungi to defeat the drugs designed to kill them.

The Last of Us, a post-apocalyptic TV series in which a brain-destroying fungus wipes out most of humanity, increased public interest in the field, but with real fungal infections already contributing to millions of deaths a year experts are urging health officials to pay more attention to the growing threat from anti-fungal resistance.

AFR is an “under-recognised component of the antimicrobial resistance crisis, which has focused largely on bacterial infections”, said Paul Verweij, professor of clinical mycology at the Netherlands’ Radboud university. “We have strong evidence that selection for resistant strains that infect people takes place in the environment through the use of agricultural fungicides,” he added.

The fungal death toll is often estimated at about 2mn a year but fungal diseases are frequently misdiagnosed, said David Denning, professor of infectious diseases at Manchester university. His revised estimates suggest that nearly double that number — 3.75mn people worldwide — die annually as a result of fungal infections.

Aspergillus species cause the most deaths. Disease begins when someone breathes in fungal spores — usually outdoors but sometimes in homes where mould has spread. The fungus then grows in the lungs, normally in people with depressed immunity or existing pulmonary problems.

When a farmer applies a fungicide, it protects the crop but also affects trillions of other fungi living in the soil and surrounding environment, which evolve resistance through a “bystander effect”.

This has important implications for human health because people are almost always infected with Aspergillus from fungus in the environment rather than from another person with aspergillosis, Denning said.

The same chemicals, azoles, are the basis of both agricultural fungicides and the antifungal drugs used to treat aspergillosis. Azole resistance levels vary around the world but are typically 10-20 per cent in environmental samples of Aspergillus from northern Europe. However, resistance can reach 50-60 per cent, according to one study in Vietnam’s Mekong Delta region.

“There is so little surveillance for fungal infections and resistance around the world that we don’t really know what’s out there,” said Tom Chiller, head of fungal diseases at the US Centers for Disease Control and Prevention.


It is harder to develop medicines to kill fungal pathogens than bacterial ones without harming patients because fungi are multicellular organisms more closely related to humans, Chiller said. “So it is particularly important to protect our limited [stock] of effective anti-fungal drugs.”

Protection would involve imposing some restrictions on the agricultural use of chemicals that kill fungi in the same way as human treatments.

An antifungal treatment called olorofim developed by the Manchester-based biotech company F2G is the first of a new drug class designed to treat azole-resistant Aspergillus. Olorofim is in clinical trials that will take at least two more years to complete, said Mike Birch, the company’s chief operating officer. Denning is a founder of F2G.

But Nippon Soda, a chemical company based in Tokyo, launched an agricultural fungicide called ipflufenoquin in Japan in 2021, which has a mechanism of action very similar to F2G’s olorofim — leading to concerns among medical mycologists that cross-resistance will evolve.

“The issue affects anyone developing antifungal drugs because regulatory requirements make the development time for human medicines much longer than for agricultural chemicals,” said Birch. “Regulators need to put in place mechanisms to balance the needs of agriculture and medicine.”

Chinami Yokota, who leads pesticide development for Nippon Soda, said: “Both medicines and agrochemicals are necessary in modern society and both must be fully effective in their respective fields. We will continue to co-operate with the reviews by national authorities and related organisations, as we make an effort to provide the information required to support the registration of our products including ipflufenoquin.”

CropLife International, an industry organisation promoting sustainable use of agricultural products, has set up an expert group that aims to limit the occurrence and spread of resistant strains of human fungal pathogens in agricultural settings, through appropriate mitigation measures.

One focus of attention is the management of accumulated waste from plants protected with azole fungicides, which CropLife said may become hotspots for resistant Aspergillus strains.

Regulators of agrochemical products, such as the US Environmental Protection Agency, have traditionally looked just at direct toxicity when assessing the effects of pesticides on people, wildlife and the environment.

But the CDC’s Chiller was encouraged that his EPA counterparts were now consulting widely about a new framework that would assess the wider risk of antifungal resistance arising from new products.

“We have to recognise the growing public health threat from resistant fungi while ensuring that farmers have effective chemicals to prevent and treat fungal diseases in crops,” Chiller said.

FT : Can ‘water batteries’ solve the energy storage conundrum?

Can ‘water batteries’ solve the energy storage conundrum?
Portuguese plant aims to show pumping water up a mountain can be part of energy system driven by renewable power

The 230-tonne metal cylinder emits a roaring hum as it spins at 600 revolutions per minute, driving a pump buried underground that brings new meaning to the idea of pushing water up a hill.

Far from the analogy of an impossible task, it is the core of a Portuguese power plant aiming to show that pumping water 7km up a mountain can be an essential — and commercially viable — part of an energy system led by renewable power.

Built by Spanish company Iberdrola at a cost of €1.5bn, the facility in a rocky river valley in northern Portugal is known as a pumped storage plant.

But insiders have another name for the reservoir at the top of the mountain. It is a “water battery” — rudimentary in concept, intricately engineered and a highly effective way of storing energy.

The Tâmega plant takes excess electricity from the grid, mostly generated by wind and solar power, and uses it to pump water from a lower reservoir to an upper one.

Surveying its placid blue surface, Rafael Chacón Llorente, Iberdrola’s project director at the complex, said: “When the water level is at 885 metres above sea level, the battery is fully charged.”

Then in peak hours, when the grid requires more power, the system is reversed on demand. A gate opens and gravity brings millions of litres of water thundering back down a tunnel every minute. The pump becomes a turbine and it spins the metal cylinder the other way, generating electricity at zero cost.


The power production is significant. The upper reservoir has a capacity of 880 megawatts, roughly a quarter of Hinkley Point C, which is set to become the UK’s biggest nuclear plant.

Because Tâmega can generate for up to 24 hours, the total amount of power stored there is 21GWh, enough to charge 400,000 electric vehicle batteries, or sustain 2.4mn homes in Portugal for a full day.

Such storage is a vital complement to the growing global role of wind and solar power in producing electricity free of carbon emissions. However, the challenge for businesses is finding the right conditions to make new pumped hydro projects economically attractive.

The problem pumped hydro solves is the variability of wind and solar power. On one hand, the sun does not always shine and the wind does not always blow.

On the other, when the sun is blazing and the wind is howling, solar panels and spinning turbines produce far more electricity than can be consumed at any one time. Because power grids cannot handle any excess, the electricity has to be stored somewhere or it will be lost.

That need for storage will only grow as renewable power expands. Portugal had 61 per cent of its electricity from renewable sources in 2023 and is aiming for 85 per cent by 2030. By the same deadline, Spain wants to hit 81 per cent.

At a plant such as Tâmega, surplus electricity can be used to “charge” the reservoir, often during the daytime. Then in the evening, when lights and appliances are on in homes, the pump is switched to turbine mode and generates power.

Diego Díaz Pilas, Iberdrola’s global head of ventures and technology, said chemical batteries also have a role to play in grid storage: Iberdrola has plans to expand the global capacity of its battery projects to 3GWh. But their scale is smaller than pumped hydro both in terms of brute power and how long they can produce electricity at full capacity (two to four hours for lithium-ion batteries, versus roughly a whole day at Tâmega).

“When you have a lot of solar, it pairs very well with batteries because solar generates in daylight hours, and batteries can be discharged when the sun is not shining,” said Díaz Pilas. “But when you have also a lot of wind — and 50 per cent of electricity will be coming from wind in Europe around 2030 — you really need to store vast amounts of energy.”

Pumped storage has been around for a century. Many facilities, such as Drax’s Cruachan plant in Scotland, were built in the 1960s to store surplus electricity from nuclear plants. Today pumped hydro accounts for more than 90 per cent of global electricity storage, a lot of it in the US, according to the International Energy Agency.

But more is needed. In Spain and Portugal, Iberdrola has 100GWh of existing pumped storage and another 170GWh under construction or in the pipeline. China has big plans to build even more.


Once constructed, the plants have long lifespans and become arbitrage plays on the electricity price. At Tâmega, Iberdrola buys power from the grid to pump when it is cheap, then sells power back when it is expensive. In Portugal’s power system on Monday, the average off-peak price of €54 per MWh compared with an on-peak price of nearly €78. “That’s how you make a margin,” said Díaz Pilas.

Another champion of pumped storage is Malcolm Turnbull, Australia’s former prime minister who when in office orchestrated the state-owned Snowy 2.0 project, which has become a byword for cost blowouts and is due to be completed in 2028 with an $8bn (A$12bn) price tag.

“Anyone that’s got a pumped hydro scheme is so happy . . . I can tell you they’re all making money,” he said in a new role as head of the International Hydropower Association. “The problem is the cost of building new ones.”

The capital expenditure required is huge and construction can take six years or more. Iberdrola got a €650mn loan from the European Investment Bank for Tâmega. Developers must also negotiate complex permitting procedures and stiff opposition from residents and environmentalists to plans to demolish homes and flood natural habitats.

That is why Iberdrola said it needed more incentives than just the price spread. At Tâmega, where the company has a licence from the Portuguese government to operate for 70 years, it also receives a steady stream of “capacity market” payments, which are paid by the grid operator in return for a guaranteed supply and other services to keep the network stable.

In the UK, energy companies look on in envy. Scotland has ample potential to use pumped hydro to store electricity generated by wind. Drax’s Cruachan plant is profitable, but mainly thanks to supply contracts signed when energy prices were high.

Ian Kinnaird, Scottish assets director at Drax, said the UK regulatory set-up “isn’t good enough” for new projects because it is not adapted to the long lead times for pumped storage. Reforms are needed, he added, to “de-risk” the financing for investors.

At Iberdrola, Díaz Pilas said: “We don’t need anything fancy . . . We just need faster permitting and stability in the regulatory framework. It’s actually funny that we are here talking about a technology that is nearly 100 years old, but it is so important for the future.”

FT : The EU’s carbon border tax and the fragmentation of global trade

The EU’s carbon border tax and the fragmentation of global trade
A levy on imports of carbon-intensive materials such as steel may help limit emissions, but producers warn it could radically alter trade flows

In Jiaxing, a manufacturing town on the outskirts of Shanghai, 400 steel industry executives and engineers gathered last November to tackle an enormous task: weaning the world’s biggest steel producer off coal-fired blast furnaces.

The subject is of burning political urgency. The Chinese government is trying to decarbonise a sector that relies heavily on coal — and quickly — or risk losing its dominance as countries with ambitious climate goals look elsewhere.

The source of China’s predicament can be traced to Europe where the EU — one of its key export markets — has imposed the world’s first ever tax on emissions of carbon-intensive imports starting with cement, iron, aluminium, fertilisers, electricity, hydrogen and, of course, steel. The levy will come into force in 2026, but the transition is already under way.

But there is a deeper concern. The EU’s decision could set into motion a wave of countries enforcing similar measures, and on a wider variety of products, delivering a devastating collective blow to Chinese industry. In December, the UK announced the introduction of its own carbon import tax by 2027.

“Companies are watching this keenly,” says Gao Liqun, partner in carbon tariffs research for Deloitte China. “They are concerned that there will be many other countries — [most importantly] the US and Japan — taking on similar measures.”

One guest at the Jiaxing event, organised by the state-owned Zhejiang Society of Metals, was feeling optimistic, however. Tan Weihan, chief executive of Xi’an Xinda Electrical Furnace Works, sees the challenge facing Chinese steelmakers as an opportunity for companies like his that are helping to create cleaner steel.

“The government is signalling the need for large-scale research and industrial co-operation,” says Tan. “We’re talking to the government and we hope to receive support.”

For Europe, the introduction of the Carbon Border Adjustment Mechanism (CBAM), has been heralded as a much-needed leveller for European companies in an increasingly fractious landscape for global trade.

But it is also a major step towards broader carbon pricing, a measure policymakers and environmentalists say is needed to cut emissions to 1.5C, the ideal goal of the Paris agreement.


Western politicians are acutely concerned about an over-reliance on China for the raw materials necessary to support the green transition. Steel, among the world’s most commonly used metals, is one of the most politicised sectors in that debate.

The EU, which is facing pressure from member states to regain its competitive edge, wants to ensure that the billions of euros being invested by steel heavyweights such as ArcelorMittal and Thyssenkrupp into their European plants to reduce emissions will not be undercut by low-cost competitors using dirtier energy sources.

Yet unease over the first measures of its kind abounds from all sides. Some European producers themselves worry that CBAM could lead to higher costs that will erode the region’s appeal and their own.

Further afield, officials and executives in countries including China, India Turkey and Brazil fear that CBAM will disrupt trade flows and create a two-tier system, with products made using clean energy sent to the EU and those produced with coal power being exported to poorer countries with less stringent climate laws.

To that end, CBAM offers an early preview of what happens when the race to decarbonise is taken at different speeds by different countries.


The EU defends its policy as a necessary measure to drive down emissions. But for Beijing, CBAM is an example of green protectionism, says Qin Yan, a carbon analyst at London Stock Exchange Group.

“The overall trend is towards trade fragmentation because of concern about supply-chain risks: everyone is afraid of being dominated by China,” she adds. “The carbon pricing mechanism gives Europe an opportunity to reshore its manufacturing.”

This shift could accelerate the deepening wedge between the Chinese economy and those in the west — and pave the way for retaliatory measures.

The cost of polluting
Persuading its trade partners of the benefits of the carbon border tax has required some effort on the EU’s part.

To win support, Brussels has been hosting a series of seminars and outreach sessions. At one such gathering of Chinese executives and officials in Beijing last November, the EU’s climate commissioner Wopke Hoekstra pressed his case: “You will see that CBAM, regardless of what people try to push for, is not a ‘penalty’ for importers to the EU, but an incentive for decarbonisation.”

He urged any Chinese exporters present “to take mitigation action and get ready to report the carbon content of their products”.

For EU officials, CBAM is the logical development of the bloc’s emissions trading system (ETS), through which European companies buy permits corresponding to the number of tonnes of Co2 they emit.

But since its introduction in 2005, the carbon price — which fluctuates according to demand — has steadily increased. As the cost of polluting rises, EU-based manufacturers already facing high energy prices worry that their greener, more expensive production will be undercut by low-cost imports from countries using coal power for fuel. EU heavy industries currently receive some free ETS permits in help them stay competitive but these will be wound down in coming years.


“The reality is that we pay for steel at a much higher price than some of our competitors,” says Luca de Meo, chief executive of French carmaker Renault. “We have seen a rise in the price of steel which is probably 8 to 10 per cent the cost of the car in Europe.”

Assofermet, the Italian steel industry body, warned at a conference in September that CBAM could push up the price of steel by 15 per cent.

But EU policymakers argue that the measure is essential to prevent “carbon leakage”, the risk that EU companies will outsource carbon intensive production elsewhere.

As she sought to win over business, European Commission president Ursula von der Leyen said last year that “making sure that a price is paid for the embedded carbon emissions generated in the production of certain goods imported into the EU” would mean their carbon price matches that of domestic production “ensuring that the EU’s climate objectives are not undermined”.

The seven sectors that policymakers have singled out as most at risk of carbon leakage will be subject to CBAM first, although the EU expects that the levy will ultimately cover a much larger number of industries.

Importers will be charged for the carbon emissions related to the production of their goods according to the EU’s ETS price with first payments due to be made in 2026.

During a trial period that started in October, companies must report their emissions to the customs authorities, but will not be taxed. The first reports must be made in January 2024 and those that do not report will face a small fine.

Countries that have a carbon price similar to that of the EU will either be exempt or will be charged relatively less according to their domestic carbon price.

China, for example, does have a rudimentary carbon pricing system covering a small number of products, but the cost hovers at about 60 renminbi (€7 to €8) per tonne, about 10 times less than the EU’s current carbon price.

Even though Beijing is considering extending this to steel and cement, Chen Zhibin, senior manager at Adelphi, a climate think-tank, says its carbon price will fall far short of the EU price come 2026.

“It won’t go up to €80 to €90,” he says. “Up to €20 is already pretty idealistic.”

Unfair trade
When CBAM was first proposed, a primary concern from some EU lawmakers was that it would fall foul of World Trade Organization rules and lead to a series of disputes.

Ahead of the first payments being made, however, worries have turned to whether the levy will work — or if it can be circumvented by earmarking lower carbon steel for the EU.

For steel, which makes up 22 per cent of the EU’s industrial carbon emissions and is the biggest CBAM sector, the risk of circumvention, or “resource shuffling”, is particularly acute.

“The steel sector entails a high degree of complexity for the CBAM,” the European Steel Association (Eurofer) warned in a paper on the topic. Not only does steel cover numerous product categories with more than 100 custom codes, it said, it also involves different production routes and emissions generated during production as well as large trade flows.

Adolfo Aiello, deputy director-general at Eurofer, says European steelmakers could face competition on multiple fronts: not just from “cheaper dirty steel” but also “greener steel from third countries”. The risk, he adds, is that the EU becomes “a demand centre for green steel” with dirty steel being diverted elsewhere. The result, he says, “would be a net negative impact on the climate”.

Some domestic producers, including Luxembourg-based multinational ArcelorMittal, welcome CBAM but believe the current scheme “has some flaws”. The levy, ArcelorMittal executives argue, should be expanded to cover a wider scope of products made with a large amount of steel, such as the components used in white goods or machinery.

Failing to do so risks pushing manufacturers in Europe — many of which build crucial green infrastructure such as solar panels and electricity cables — to offshore production.

“The margins of [some of] these industries which are our customers and which consume steel in Europe are already extremely compressed. Then you add another handicap,” says Laurent Plasman, chief marketing officer at ArcelorMittal Europe. “The big concern we have is that companies will simply decide this thing is too much and will localise production elsewhere.”

The wind sector, which requires large steel plates for its turbines, has echoed these fears. Only taxing raw materials “could distort the EU wind industry’s supply chain”, the industry body Wind Europe warned in a paper.

These are the kinds of knock-on effects that will be taken into consideration during the trial period “and we will try and understand if we need an adjustment”, one senior EU official says.

Some producers say it is in the interests of European industries to adapt in order to remain competitive — and ensure the CBAM is successful.

Jose Noldin, chief executive of start-up GravitHy, which plans to build the first green iron plant in France using hydrogen made from renewable sources, warns there is a “risk that European producers don’t embrace change and are outpaced by producers in other regions”.

“EU industry is naturally positioned for example to lead the harmonisation of green standards, definitions . . . and certifications, which is essential for CBAM to work properly,” he adds.

Playing defence
At an event in Brussels in November, Fu Cong, the Chinese ambassador to the EU, made clear his country’s feelings about the tax on carbon.

He argued that the initiative was “another green trade barrier” — a view he warned was shared by “many other developing countries and by the US”. China is one of several countries still threatening WTO complaints.

China has already spoken out against other trade defence measures being taken by the EU and the US, such as the EU’s anti-subsidy probe into Chinese electric vehicles, which Beijing sees as a stealth form of protectionism. In response, China has launched an anti-dumping investigation into imports of French brandy.

Other countries opposed to the CBAM are using the growing discontent as an opening. Mehmet Fatih Kacir, Turkey’s industry minister, says that the EU should see his country as a reliable alternative to China for competitively priced solar panels, electric vehicles and wind turbines.

But there is a catch: because of its proximity to the EU and its inclusion in the customs union that allows such goods to enter the single market without tariffs or quotas, Turkey should be exempt from CBAM, he argues. “Clearly, we think that the border of the customs union should be the border of the carbon trade,” Kacir adds.

Meanwhile, the Indian industry minister Piyush Goyal has branded the CBAM an “ill-conceived” tax and says he expects EU companies to move production to India as a result.

The European Commission has pushed back strongly against any claims that CBAM is incompatible with WTO standards or will upset global trade.

“The EU lawyers who made CBAM are 100 per cent convinced that it is WTO compliant because we are applying the same levies to domestic producers as outside producers,” one EU official says.

What will the US do?
Further down the line there is another obstacle for CBAM. From 2025, only the EU method of emissions accounting will be accepted.

Japanese steelmakers are among those that have taken issue with Brussels over the detail of reporting required and the potential fines that could be incurred even during the trial period. Even the commission’s own impact assessment estimates that complying with CBAM could cost companies up to €27mn per year.

In the run-up to December’s COP28, the UN’s annual climate conference, ambitious western nations have stepped up their call for a global carbon price, pitching it as a way to incentivise businesses to cut emissions.

This approach, they hope, will prevent a fragmentation of global markets into “cleaner” and “dirtier” ones. The summit was the first to feature a trade day, a sign of the issue’s growing importance as a tool for climate action.

There are signs of a shift. Canada’s “carbon pricing challenge”, an initiative launched at COP26 in 2021 that aims for 60 per cent of global emissions to be subject to permits by 2030, has gathered momentum this year, with the EU signing up in November.

Countries with “strong carbon pricing systems must prevent carbon leakage and freeriding from low-ambition countries, or their own decarbonisation plans will not be politically viable”, warns Simone Tagliapetra, senior fellow at the Brussels-based think-tank Bruegel. “The EU is just the first to face this.”

But in lieu of a global carbon price, other countries including Canada and Australia are watching EU’s CBAM closely with an eye to introducing their own. Canberra’s review of whether it should implement a carbon border tax will be published next year. The UK government said its planned CBAM is subject to further consultation, including which products it will cover.

The biggest fear for Chinese companies, however, is the prospect of a carbon border tax in the US, says Li Shuo, director of China climate research at the Asia Society Policy Institute.

“For most of the Chinese analysts and government officials, when they talk about CBAM, what’s really on their mind is what the US will do,” he says. “Will the US impose its own carbon tax in the future? It’s reasonable for us to assume that [such a tax would] be less in line with any WTO-related considerations, more hostile, and harsher.”

On November 2, three Republican senators introduced the Foreign Pollution Fee Act, which would charge imports of certain products according to how “dirty” they are compared to US-made alternatives. A similar bill with a focus on domestic production as well was proposed by Democrats in December. But as the US does not have its own emissions trading system, analysts say such measures are more likely to fall foul of WTO rules.

The greater risk, however, is that CBAMs will eventually materialise throughout the world but without common definitions for minimum standards for products such as green steel or guidelines for best practice, according to the European Roundtable on Climate Change and Sustainable Transition. The outcome, their analysts say, would be ineffective climate policy — and confusion for producers.

Mohammed Chahim, a Dutch lawmaker who led negotiations on the CBAM proposal in Brussels, suggests there is a straightforward solution: other countries should simply align with the EU. “We [could] adjust ours a bit but at least we co-ordinate on how it is applied because otherwise it will fragment global trade,” he says.

But in an ideal world he would wish for the CBAM to “never be implemented”.

“That [would] mean economies outside the EU are cleaner or they have introduced their own carbon emissions system,” he adds. “And I’m OK with that.”

>>> US After Hours Summary

After Hours Summary: MXCT +11.5% up on guidance; URBN +6% up on solid holiday sales; U +3.6% higher after workforce reduction; EXTR -8.8%, TCS -8.5%, MCHP -4.3% all down on guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: MXCT +11.5% (guidance), ACCD +0.8%, SAND +0.2% (guidance)

Companies trading higher in after hours in reaction to news: AVIR +6.1% (positive initial data from Phase 2 study), URBN +6% (reports holiday sales), U +3.6% (reducing workforce by 25%), RKLB +2.3% (awarded $515 mln contract), JBLU +1.7% (names new CEO, also reaffirms Q4 guidance), AB +0.4% (names new CFO), GOOD +0.2% (provides business update)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: EXTR -8.8% (guidance), TCS -8.5% (guidance), MCHP -4.3% (guidance), JEF -3.1%, ZUMZ -2% (guidance), DHR -1% (guidance)

Companies trading lower in after hours in reaction to news: DENN -3.9% (expansive agreement with Franklin Junction), ES -3% (recording impairment charge), AKR -2.7% (stock offering), CAAP -1.7% (receives gross indemnification payment), SCLX -1.4% (files mixed shelf), PTEN -1.2% (December drilling data), NUVB -0.6% (IND app cleared by FDA)

WSJ : Novartis in Advanced Talks to Buy Cytokinetics

Novartis in Advanced Talks to Buy Cytokinetics
Acquisition would be latest in a flurry of deals by pharmaceutical giants for hot biotechs

Novartis NOVN 0.43%increase; green up pointing triangle is close to clinching an acquisition of Cytokinetics CYTK 10.26%increase; green up pointing triangle and its promising heart drug, as big pharma companies continue to snap up fast-growing biotechs to replenish their pipelines.

A purchase by the Swiss drug company of South San Francisco-based Cytokinetics, which has a market value of about $9 billion, could be finalized as soon as this week, according to people familiar with the situation. Cytokinetics has been running a sale process and it’s possible another suitor could reemerge; there also may be no deal at all.

The potential price and other terms couldn’t be learned.

Cytokinetics is focused on so-called muscle activators and inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised, according to its website.

The company’s shares soared last month on the back of successful data for its experimental heart drug that treats hypertrophic cardiomyopathy, the most common genetic heart disease, which can lead to blood clots, strokes and, in rare cases, death.